MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$5,490K
Other segment expense
$218K
Other income, net
$81K
Research and
development-TIDAL-01
-$48K
General and
administrative
$5,388K
Research and
development-Compensation
$406K
Depreciation expense
$31K
Provision for income taxes
$12K
Back
Back
Income Statement
source: myfinsight.com
Turnstone Biologics Corp. (TSBX)
Turnstone Biologics Corp. (TSBX)